Weijing Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors.
Journal: Haematologica
Published: November 09, 2022
Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.
Journal: Aging
Published: January 30, 2021
PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
Journal: BMC cancer
Published: October 16, 2017
CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells.
Journal: International journal of nanomedicine
Published: November 16, 2016
A pharmacokinetic and safety study of a fixed oral dose of enzastaurin HCl in native Chinese patients with refractory solid tumors and lymphoma.
Journal: Oncotarget
Published: November 07, 2015
Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization.
Journal: Oncoimmunology
Published: August 21, 2015
Distinctive translational and self-rotational motion of lymphoma cells in an optically induced non-rotational alternating current electric field.
Journal: Biomicrofluidics
Published: January 11, 2015
Quantitative analysis of drug-induced complement-mediated cytotoxic effect on single tumor cells using atomic force microscopy and fluorescence microscopy.
Journal: IEEE transactions on nanobioscience
Published: November 25, 2014
Last Updated: 09/26/2026